TRACER PHARMA ApS: Financial statements 2018
CVR: 34090106
Source: annual report 2018, Danish Business Authority
01/05/2017 – 30/04/2018
TRACER PHARMA ApS (CVR 34090106) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 3,300,692 and a net result of DKK 417,388 compared with DKK 20,350 the year before. That is an increase of 31.5% compared with the year before. Equity in the 2018 report amounted to DKK 524,828. The solvency ratio was 17.6%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 3,300,692
- Profit/Loss
- DKK 417,388
- Equity
- DKK 524,828
- Total Assets
- DKK 2,989,570
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 3.3 mio. | 417 t. | 525 t. | 4 |
| 2017 | - | 2.5 mio. | 20 t. | 227 t. | 4 |
| 2016 | - | 3.1 mio. | 123 t. | 207 t. | - |
| 2015 | - | 2.2 mio. | 30 t. | 114 t. | - |
| 2014 | - | 2 mio. | 123 t. | 204 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout TRACER PHARMA ApS
TRACER PHARMA ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2011. The company has been dissolved on 28 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 5,203,816 and a net result of DKK 687,871 compared with DKK 1,705,344 the year before. Equity in the 2025 report amounted to DKK 867,174.